NTLA
Intellia Therapeutics, Inc
$12.42
-6.57%
-0.87
Notify me if price changes either direction
Buy NTLA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.5B
Enterprise value
1.2B
Trailing PE
-3.249343862058
Forward PE
-4.234822
PEG Ratio
0.093787879654855
Enterprise to EBITDA
-2.8
Enterprise to revenue
17.844
Price to book MRQ
2.1431048
Price to sales TTM
21.594358
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
67.7M
EBITDA
-431223008
Diluted EPS TTM
-3.81
Total Cash (MRQ)
449.9M
Current ratio (MRQ)
5.08
Operating Cash Flow (TTM)
-394736000
NTLA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
